Modern image-guided radiation treatments of lung and prostate cancer routinely use radioopaque implantable devices, such as gold fiducials or brachytherapy spacers, for increasing spatial accuracy. Currently these implants do not have any function besides locating the tumor. The therapeutic efficiency of IGRT can be further enhanced by biological in-situ dose painting (BIS-IGRT) of radiosensitizers through localized delivery within the tumor using gold fiducial markers that have been coated with nanoporous polymer matrices loaded with nanoparticles. Here we show that gold fiducials can be coated with slow-releasing anti-cancer or radio-sensitizing drugs prior to implantation. We fabricated nanoporous coatings consisting of polymer films on gold fiducials. The coatings were loaded with free drug or polymer nanoparticles containing drugs. Sustained release of drug and drug-loaded nanoparticles over a course of forty days was observed. The released drug provides both tumoricidal as well as radio-sensitization functionalities to the implant. This novel approach can be tailored by manipulating the degradation rate of the host coating to achieve the desired release profile to match the treatment plan that is needed for successful radiation therapy of cancer.
